Pharma Now is now the official partner of the 2nd Annual Structure-Based Drug Design Exhibition

Pharma Now is excited to announce its official media partnership with the 2nd Annual Structure-Based Drug Design, which will be taking place from June 3–5, 2025, at the Revere Hotel in Boston, MA. This partnership is a testament to Pharma Now’s commitment to delivering cutting-edge insights at the intersection of structural biology and drug discovery.

The summit is one of the most prestigious pharma events dedicated to advancing integrative structural biology techniques—including Cryo-EM, NMR, X-ray crystallography, and AI-driven modeling—to elucidate 3D structures of pharmacologically relevant targets. These methodologies are instrumental in accelerating the development of therapeutics across various modalities, including small molecules, biologics, peptides, and mRNA-based drugs. 

For the unversed, the exhibition will feature sessions from Alexey Rak, Head of Bio Structure and Biophysics (Sanofi), Ann Boriack-Sjodin, Executive Director & Global Head of Structural Biology (Takeda Pharmaceutical), Dave Brown, Senior Director (Vertex Pharmaceuticals), Seungil Han, Head Research of Cryo-Em & Structural Biology Lab Fellow (Pfizer), Sonja Kuhn, Head of Structural Biophysics & Computational Chemistry Research (Servier) and Ye Che, Senior Director (GlaxoSmithKline).

“We are thrilled to partner with such a prestigious event,” said Ravindra Warang, Editor-in-Chief of Pharma Now. “This collaboration strengthens our commitment to delivering the latest and most impactful news in drug development. The insights shared at the 2nd Annual Structure-Based Drug Design Exhibition will play a crucial role in transforming the future of medicine.”

Join us for an exclusive opportunity to get detailed event coverage as Pharma Now brings you the best from the exhibition, making this partnership a cornerstone for innovation and progress in pharmaceutical sciences.